Reuters logo
BRIEF-Abbott, Bigfoot Biomedical enter deal to develop diabetes management systems
July 13, 2017 / 11:40 AM / 2 months ago

BRIEF-Abbott, Bigfoot Biomedical enter deal to develop diabetes management systems

July 13 (Reuters) - Abbott Laboratories:

* Abbott Laboratories and Bigfoot Biomedical enter agreement to develop and commercialize diabetes management systems

* Abbott says financial terms of the agreement with Bigfoot are not being disclosed

* Abbott says will supply glucose measurement sensors for all of Bigfoot’s insulin delivery systems in U.S. as exclusive sensors for those systems

* Bigfoot will develop and commercialize multiple systems using Abbott’s freestyle libre sensor technology

* In the U.S., freestyle libre system is currently pending approval by the U.S. Food and Drug Administration Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below